1-4 of 4
Ibrahim Syed
Close
Sort by
Journal Articles

Clinical Features of Idiopathic Erythrocytosis in a Racially Diverse Population

Caitlin O'Neill, MD, Ah-Reum Jeong, MD, Ibrahim Syed, Casey L. O'Connell, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-141372
Published: 2020
Journal Articles

The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19

Lantarima Bhoopat, MD, Anastasia Martynova, MD, April Choi, MD, Pattharawin Pattharanitima, MD, Semi Han, MD, Senxi Du, Ibrahim Syed, Catherine Chan, PharmD, Caitlin O'Neill, MD, Esther Oh, PharmD, Casey L. O'Connell, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-141732
Published: 2020
Journal Articles

Microtransplantation: HLA-Mismatched Allogeneic Cellular Therapy of Acute Myeloid Leukemia (HMMACT)

Ann Mohrbacher, MD, Ibrahim Syed, Noah Merin, MD PhD, Giridharan Ramsingh, MD, Susan Groshen, PhD, Preet Chaudhary, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5944.
https://doi.org/10.1182/blood.V124.21.5944.5944
Published: 2014
Journal Articles

Results From the Dose Escalation Phase of a Randomized Phase 1–2 First-in-Human (FIH) Study of SGI-110, a Novel Low Volume Stable Subcutaneous (SQ) Second Generation Hypomethylating Agent (HMA) in Patients with Relapsed/Refractory MDS and AML

Hagop M. Kantarjian, MD, Gail J. Roboz, MD, David A. Rizzieri, MD, Wendy Stock, MD, Casey L. O'Connell, MD, Elizabeth A Griffiths, MD, Karen Yee, MD, Raoul Tibes, MD, Guillermo Garcia-Manero, MD, Farhad Ravandi, MD, Katherine Walsh, MD, Eric Feldman, MD, Ellen Ritchie, MD, Arati Rao, MD, Carlos Decastro, MD, Aaron D. Schimmer, MD, Ruben A. Mesa, Ibrahim Syed, MBBS, Gavin Choy, PharmD, Aram Oganesian, PhD, Pietro Taverna, PhD, Mohammad Azab, MD, Woonbok Chung, PhD, Jean-Pierre Issa, MD
Journal: Blood
Blood (2012) 120 (21): 414.
https://doi.org/10.1182/blood.V120.21.414.414
Published: 2012